100 related articles for article (PubMed ID: 10328848)
1. A multicopy c-Myc transgene as a nuclear label: overgrowth of Myctg50 cells in allophenic mice.
Augustin M; Klopp N; Ewald K; Jockusch H
Cell Biol Int; 1998; 22(6):401-11. PubMed ID: 10328848
[TBL] [Abstract][Full Text] [Related]
2. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
3. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay.
Hirabayashi Y; Inoue T; Suda Y; Aizawa S; Ikawa Y; Kanisawa M
Exp Hematol; 1992 Feb; 20(2):167-72. PubMed ID: 1544384
[TBL] [Abstract][Full Text] [Related]
4. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains.
Kunert-Keil C; Bisping F; Krüger J; Brinkmeier H
BMC Genomics; 2006 Jun; 7():159. PubMed ID: 16787531
[TBL] [Abstract][Full Text] [Related]
7. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
8. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
9. Increased transcription of the E mu-myc transgene and mRNA stabilisation produce only a modest elevation in Myc protein.
Colley SM; Tilbrook PA; Klinken SP
Oncogene; 1997 Jun; 14(22):2735-9. PubMed ID: 9178772
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligodeoxynucleoside methylphosphonate inhibition of mouse c-myc p65 protein expression in E mu-c-myc transgenic mice.
Wickstrom E; Bacon TA; Wickstrom EL; Werking CM; Palmiter RD; Brinster RL; Sandgren EP
Nucleic Acids Symp Ser; 1991; (24):151-4. PubMed ID: 1841270
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
Liu P; Zhao Z; Dominique B
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
[TBL] [Abstract][Full Text] [Related]
12. Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome.
Durkin ME; Keck-Waggoner CL; Popescu NC; Thorgeirsson SS
Genomics; 2001 Apr; 73(1):20-7. PubMed ID: 11352562
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
14. Effects of light and food schedules on liver and tumor molecular clocks in mice.
Filipski E; Innominato PF; Wu M; Li XM; Iacobelli S; Xian LJ; Lévi F
J Natl Cancer Inst; 2005 Apr; 97(7):507-17. PubMed ID: 15812076
[TBL] [Abstract][Full Text] [Related]
15. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
16. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
17. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.
Pascal SM; Guiot Y; Pelengaris S; Khan M; Jonas JC
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E92-102. PubMed ID: 18413670
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
Christensen JG; Goldsworthy TL; Cattley RC
Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
[TBL] [Abstract][Full Text] [Related]
19. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
20. c-myc Internal ribosome entry site activity is developmentally controlled and subjected to a strong translational repression in adult transgenic mice.
Créancier L; Mercier P; Prats AC; Morello D
Mol Cell Biol; 2001 Mar; 21(5):1833-40. PubMed ID: 11238920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
